PTPN2 inhibitor therapy(Ness Therapeutics)

N/A

Report date: 2024/05/28 16:39:28
NME

Base Information

Drug NamePTPN2 inhibitor therapy(Ness Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein phosphatase non-receptor type 2 inhibitors
TargetsTyrosine-protein phosphatase non-receptor type 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEilean Therapeutics LLCNess Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesExpert Systems IncNess Therapeutics IncEilean Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A